StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by Bucky86on Oct 26, 2020 1:39pm

154 Views

Post# 31782228

RE:RE:RE:RE:pp for 3000 test a day

I'm with you on the revenue prediction. I'm calling sub 2 mill but that's still decently impressive obviously. But the only thing we can do is wait for Q3. That's why its make or break time. I've been in this company for 3+ years... I knew what I was getting into but we all have to make personal decisions on what we see long term with our investments.

Bullboard Posts

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles